Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$209.01 - $232.56 $14,630 - $16,279
-70 Reduced 1.7%
4,040 $882,000
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $15,815 - $18,183
-80 Reduced 1.91%
4,110 $934,000
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $1.14 Million - $1.26 Million
-5,676 Reduced 57.53%
4,190 $842,000
Q2 2023

Aug 11, 2023

BUY
$211.93 - $241.33 $1.18 Million - $1.34 Million
5,556 Added 128.91%
9,866 $2.38 Million
Q1 2023

May 12, 2023

SELL
$213.32 - $257.83 $2.2 Million - $2.66 Million
-10,336 Reduced 70.57%
4,310 $988,000
Q4 2022

Feb 24, 2023

SELL
$203.72 - $248.97 $25,465 - $31,121
-125 Reduced 0.85%
14,646 $3.45 Million
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $914,906 - $1.12 Million
4,491 Added 43.69%
14,771 $3.48 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $1.21 Million - $1.54 Million
-5,890 Reduced 36.43%
10,280 $2.11 Million
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $32.7 Million - $42.5 Million
-153,063 Reduced 90.45%
16,170 $3.79 Million
Q1 2022

May 13, 2022

BUY
$259.82 - $298.18 $38.9 Million - $44.7 Million
149,749 Added 768.57%
169,233 $44.6 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $11.5 Million - $13.3 Million
-42,190 Reduced 68.41%
19,484 $6.12 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $10 Million - $11.3 Million
36,567 Added 145.64%
61,674 $17.4 Million
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $120,897 - $133,507
480 Added 1.95%
25,107 $6.93 Million
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $4.8 Million - $5.97 Million
-23,404 Reduced 48.73%
24,627 $6.28 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $7.74 Million - $8.88 Million
41,418 Added 626.31%
48,031 $9.78 Million
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $1.82 Million - $2.19 Million
-10,904 Reduced 62.25%
6,613 $1.25 Million
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $1.98 Million - $3.2 Million
17,517 New
17,517 $2.91 Million
Q1 2020

May 14, 2020

SELL
$104.32 - $195.28 $3.45 Million - $6.45 Million
-33,029 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $5.4 Million - $5.73 Million
33,029 New
33,029 $5.56 Million
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $17 Million - $21.5 Million
-137,767 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$120.82 - $174.09 $12 Million - $17.3 Million
99,096 Added 256.25%
137,767 $17.4 Million
Q3 2018

Nov 14, 2018

BUY
$167.67 - $188.27 $982,713 - $1.1 Million
5,861 Added 17.86%
38,671 $6.72 Million
Q2 2018

Aug 14, 2018

SELL
$160.33 - $189.41 $887,426 - $1.05 Million
-5,535 Reduced 14.43%
32,810 $5.89 Million
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $6.19 Million - $6.83 Million
38,345 New
38,345 $6.2 Million
Q4 2017

Feb 14, 2018

SELL
$147.99 - $163.95 $1.61 Million - $1.78 Million
-10,849 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $1.62 Million - $1.74 Million
10,849
10,849 $1.64 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.